Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 6.

Crenn, V., Biteau, K., Amiaud, J. et al. (8 more authors) (2017) Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy : retrospective analysis and preclinical modeling. American Journal of Cancer Research, 7 (11). pp. 2333-2349.

Guiho, R., Biteau, K., Grisendi, G. et al. (6 more authors) (2016) TRAIL Delivered by Mesenchymal Stromal/Stem Cells Counteracts Tumor Development in Orthotopic Ewing Sarcoma Models. International Journal of Cancer. ISSN 0020-7136

Biteau, K., Guiho, R., Chatelais, M. et al. (5 more authors) (2016) L-MTP-PE and zoledronic acid combination in osteosarcoma: pre-clinical evidence of positive therapeutic combination for clinical transfer. American Journal of Cancer Research, 6 (3). 0025208. pp. 677-689. ISSN 2156-6976

Guiho, R., Biteau, K., Heymann, D. et al. (1 more author) (2015) TRAIL-based therapy in pediatric bone tumors: how to overcome resistance. Future Oncology, 11 (3). pp. 535-542. ISSN 1479-6694

Lamoureux, F., Baud'huin, M., Ory, B. et al. (5 more authors) (2014) Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma. Oncotarget, 5 (17). pp. 7805-7819. ISSN 1949-2553

Picarda, G., Surget, S., Guiho, R. et al. (7 more authors) (2012) A Functional, New Short Isoform of Death Receptor 4 in Ewing's Sarcoma Cell Lines May be Involved in TRAIL Sensitivity/Resistance Mechanisms. Molecular Cancer Research, 10 (3). pp. 336-346. ISSN 1541-7786

This list was generated on Sun Jul 5 03:51:06 2020 BST.